Related Experiment Video
Updated: Apr 3, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract
Grażyna Krzemień1, Tomasz Książczyk2, Agnieszka Szmigielska1
1Department of Pediatrics and Nephrology, The Medical University of Warsaw, Poland.
Insights
Ceftriaxone treatment can cause biliary sludge and pseudolithiasis, a usually asymptomatic complication. Monitoring is recommended for patients on this antibiotic to detect these gallbladder changes.
Area of Science:
- Pediatric infectious diseases
- Gastroenterology
- Pharmacology
Background:
- Ceftriaxone is a widely used antibiotic for various infections.
- Biliary sludge and pseudolithiasis are known potential side effects of ceftriaxone treatment.
- These complications typically occur in 3-57% of patients and are often asymptomatic.
Observation:
- A case study involving a 5-month-old boy treated for acute pyelonephritis is presented.
- Routine ultrasound revealed gallbladder enlargement on the 5th day of ceftriaxone therapy.
- Subsequent ultrasounds showed the development of biliary sludge, with no clinical symptoms observed.
Findings:
- The patient exhibited gallbladder enlargement and biliary sludge during ceftriaxone treatment.
- These findings are consistent with known ceftriaxone-induced biliary complications.
- The gallbladder abnormalities resolved completely six weeks after discontinuing the antibiotic.
Implications:
- Healthcare providers should be aware of the potential for ceftriaxone-induced biliary sludge and pseudolithiasis.
- Monitoring patients on ceftriaxone, particularly with prolonged use or in pediatric populations, may be warranted.
- Early detection and discontinuation of the drug can lead to resolution of these biliary complications.
Unlabelled:
Biliary sludge and/or biliary pseudolithiasis occur in patients treated with ceftriaxone with prevalence of 3-57%. Biliary obstruction can be the cause of the acute gallbladder enlargement. It is a minor complication, that usually does not give clinical symptoms and resolves once the drug is discontinued. The authors present a case of a 5-month old boy treated for the acute pyelonephritis. Routine ultrasound, performed on the 5th day of treatment with ceftriaxone, showed gallbladder enlargement. In the consecutive studies small gallblader sludge was visible. Patient had no symptoms related to the gallbladder enlargement. Ultrasound performed 6 weeks from the drug discontinuation was completely normal.
Conclusions:
Patients treated with ceftroiaxone should be monitored for biliary sludge and pseudolithiasis.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Bacterial Gastroenteritis
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection I: Introduction

